CytoDyn (CYDY) Capital Expenditures (2010 - 2022)
CytoDyn's (CYDY) quarterly Capital Expenditures came in at $17000.0 in Q1 2022, down 26.09% YoY from $23000.0 in Q1 2021, and up 240.0% on a QoQ basis from $5000.0 in Q4 2021.
CytoDyn (CYDY) Capital Expenditures (2010 - 2022) Analysis & Trends
CytoDyn (CYDY) has 13 years of Capital Expenditures data on file, last reported at $17000.0 in Q1 2022.
- Quarterly Capital Expenditures fell 26.09% year-over-year to $17000.0 in Q1 2022, while the trailing twelve-month figure through Feb 2022 was $52000.0 (down 49.51% YoY) and the FY2021 annual result came in at $122000.0, up 197.56% from the prior year.
- Capital Expenditures rose to $17000.0 in Q1 2022, from $5000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $59000.0 in Q3 2020 to a low of $920.0 in Q1 2019.
- A 5-year average of $15642.9 and a median of $13000.0 in 2019 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 2508.7% in 2020, down 86.85% in 2020.
- Tracing CYDY's Capital Expenditures over 5 years: stood at $2262.0 in 2018, then jumped by 297.88% to $9000.0 in 2019, then surged by 100.0% to $18000.0 in 2020, then tumbled by 72.22% to $5000.0 in 2021, then jumped by 240.0% to $17000.0 in 2022.
- The last three Capital Expenditures figures came in at $17000.0 (Q1 2022), $5000.0 (Q4 2021), and $8000.0 (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | CytoDyn | 258.01 Mn | 258.01 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2022 | 17,000.00 |
| Feb 28, 2022 | 17,000.00 |
| Nov 30, 2021 | 5,000.00 |
| Nov 30, 2021 | 5,000.00 |
| Aug 31, 2021 | 8,000.00 |
| Aug 31, 2021 | 8,000.00 |
| May 31, 2021 | 22,000.00 |
| May 31, 2021 | 22,000.00 |
| Feb 28, 2021 | 23,000.00 |
| Feb 28, 2021 | 23,000.00 |
| Nov 30, 2020 | 18,000.00 |
| Nov 30, 2020 | 18,000.00 |
| Aug 31, 2020 | 59,000.00 |
| Aug 31, 2020 | 59,000.00 |
| May 31, 2020 | 3,000.00 |
| May 31, 2020 | 3,000.00 |
| Feb 29, 2020 | 24,000.00 |
| Feb 29, 2020 | 24,000.00 |
| Nov 30, 2019 | 9,000.00 |
| Nov 30, 2019 | 9,000.00 |